Literature DB >> 21906829

Lower extremity strength and hopping and jumping ground reaction forces in children with neurofibromatosis type 1.

Barbara A Johnson1, Bruce Macwilliams, John C Carey, David H Viskochil, Jacques L D'Astous, David A Stevenson.   

Abstract

The purpose of this study was to (1) extend the research findings of decreased muscular force production in grip strength to the lower extremity strength of children with NF1 and (2) to determine if there was a relationship between isometric strength and functional activities in children with NF1. Force production was assessed using a hand held dynamometer (HHD) and a functional task (hopping and jumping) on a force plate. Data from twenty-six children with NF1 were compared to data from 48 typically developing children of similar sex, weight and height. Children with NF1 demonstrated statistically significant lower force production with HHD (p<0.01) during hip extension, but similar force production for knee extension and ankle plantar flexion compared to the control group. A relationship existed between the ground reaction forces at take-off from both hopping and jumping and the force generated from knee extensor strength in the NF1 group. The addition of a functional task to hand held dynamometry is useful for determining a relationship between common clinical measures and functional activities.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21906829      PMCID: PMC3243780          DOI: 10.1016/j.humov.2011.05.004

Source DB:  PubMed          Journal:  Hum Mov Sci        ISSN: 0167-9457            Impact factor:   2.161


  21 in total

1.  Force, work and power output of lower limb muscles during human maximal-effort countermovement jumping.

Authors:  Akinori Nagano; Taku Komura; Senshi Fukashiro; Ryutaro Himeno
Journal:  J Electromyogr Kinesiol       Date:  2005-08       Impact factor: 2.368

2.  Reliability of ground reaction forces during a vertical jump: implications for functional strength assessment.

Authors:  M L Cordova; C W Armstrong
Journal:  J Athl Train       Date:  1996-10       Impact factor: 2.860

3.  Power-time, force-time, and velocity-time curve analysis of the countermovement jump: impact of training.

Authors:  Prue Cormie; Jeffrey M McBride; Grant O McCaulley
Journal:  J Strength Cond Res       Date:  2009-01       Impact factor: 3.775

4.  Bone mineral density in children with neurofibromatosis type 1.

Authors:  David A Stevenson; Mary Murray; David H Viskochil; John C Carey; Laurie J Moyer-Mileur
Journal:  J Pediatr Orthop       Date:  2008 Oct-Nov       Impact factor: 2.324

5.  Decreased bone mineral density and content in neurofibromatosis type 1: lowest local values are located in the load-carrying parts of the body.

Authors:  T Kuorilehto; M Pöyhönen; R Bloigu; J Heikkinen; K Väänänen; Juha Peltonen
Journal:  Osteoporos Int       Date:  2004-11-16       Impact factor: 4.507

6.  Motor proficiency in children with neurofibromatosis type 1.

Authors:  Barbara A Johnson; Bruce A MacWilliams; John C Carey; David H Viskochil; Jacques L D'Astous; David A Stevenson
Journal:  Pediatr Phys Ther       Date:  2010       Impact factor: 3.049

7.  Bilateral comparison of propulsion mechanics during single-leg vertical jumping.

Authors:  Michael T McElveen; Bryan L Riemann; George J Davies
Journal:  J Strength Cond Res       Date:  2010-02       Impact factor: 3.775

8.  Bone health and fracture rate in individuals with neurofibromatosis 1 (NF1).

Authors:  T Tucker; C Schnabel; M Hartmann; R E Friedrich; I Frieling; H-P Kruse; V-F Mautner; J M Friedman
Journal:  J Med Genet       Date:  2008-12-09       Impact factor: 6.318

9.  Muscular force is reduced in neurofibromatosis type 1.

Authors:  J F Souza; R L F Passos; A C M Guedes; N A Rezende; L O C Rodrigues
Journal:  J Musculoskelet Neuronal Interact       Date:  2009 Jan-Mar       Impact factor: 2.041

10.  Orthopaedic manifestations of neurofibromatosis in children: an update.

Authors:  Michael G Vitale; Abhijit Guha; David L Skaggs
Journal:  Clin Orthop Relat Res       Date:  2002-08       Impact factor: 4.176

View more
  4 in total

1.  NF1 is a critical regulator of muscle development and metabolism.

Authors:  Kate Sullivan; Jad El-Hoss; Kate G R Quinlan; Nikita Deo; Fleur Garton; Jane T C Seto; Marie Gdalevitch; Nigel Turner; Gregory J Cooney; Mateusz Kolanczyk; Kathryn N North; David G Little; Aaron Schindeler
Journal:  Hum Mol Genet       Date:  2013-10-24       Impact factor: 6.150

Review 2.  Skeletal muscle and motor deficits in Neurofibromatosis Type 1.

Authors:  M A Summers; K G Quinlan; J M Payne; D G Little; K N North; A Schindeler
Journal:  J Musculoskelet Neuronal Interact       Date:  2015-06       Impact factor: 2.041

Review 3.  The skeletal muscle phenotype of children with Neurofibromatosis Type 1 - A clinical perspective.

Authors:  Amish Chinoy; Grace R Vassallo; Emma Burkitt Wright; Judith Eelloo; Siobhan West; Eileen Hupton; Paula Galloway; Amy Pilkington; Raja Padidela; M Zulf Mughal
Journal:  J Musculoskelet Neuronal Interact       Date:  2022-03-01       Impact factor: 1.864

4.  Reliability of Handheld Dynamometry to Measure Focal Muscle Weakness in Neurofibromatosis Types 1 and 2.

Authors:  Srivandana Akshintala; Nashwa Khalil; Kaleb Yohay; Alona Muzikansky; Jeffrey Allen; Anna Yaffe; Andrea M Gross; Michael J Fisher; Jaishri O Blakeley; Beverly Oberlander; Miriam Pudel; Celia Engelson; Jaime Obletz; Carole Mitchell; Brigitte C Widemann; David A Stevenson; Scott R Plotkin
Journal:  Neurology       Date:  2021-07-06       Impact factor: 11.800

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.